Article
Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study.
Antiviral therapy - 1 Jan 2018
Thanapirom Kessarin, Suksawatamnuay Sirinporn, Sukeepaisarnjaroen Wattana, Treeprasertsuk Sombat, Tanwandee Tawesak, Charatcharoenwitthaya Phunchai, Thongsawat Satawat, Leerapun Apinya, Piratvisuth Teerha, Boonsirichan Rattana, Bunchorntavakul Chalermrat, Pattanasirigool Chaowalit, Pornthisarn Bubpha, Tuntipanichteerakul Supoj, Sripariwuth Ekawee, Jeamsripong Woramon, Sanpajit Theeranun, Poovorawan Yong, Komolmit Piyawat
Abstract excerpt
BACKGROUND: Sodium taurocholate co-transporting polypeptide (NTCP) is a cell receptor for HBV. The S267F variant on the NTCP gene is inversely associated with the chronicity of HBV infection, progression to cirrhosis and hepatocellular carcinoma in East Asian populations. The aim of this study was to determine whether the S267F variant was associated with response to pegylated interferon (PEG-IFN) in patients...
Topics
- Adult
- Alleles
- Amino Acid Substitution
- Antiviral Agents
- Biomarkers
- Drug Therapy, Combination
- Female
- Genotype
